跳至主要内容
临床试验/ACTRN12621001146886
ACTRN12621001146886招募中未知

A comprehensive ImmuNe-related adVerse Event (irAE) database associated with immune checkpoint use in SouTh WEst SyDney to investigate mechanisms and impact of adverse effects in patients with cancer.

Western Sydney University0 个研究点目标入组 120 人开始时间: 2021年8月25日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • All patients with histologically or cytologically confirmed solid organ malignancies starting immune checkpoint inhibitors alone or in combination with chemotherapy
  • Patients receiving treatment in either the adjuvant or metastatic settings
  • Age >= 18 years
  • Ability to provide informed consent for the study procedures and data collection
  • Willingness and ability to comply with the study requirements
  • Signed, written informed consent

排除标准

  • Patients with prior exposure to immune checkpoint inhibitors

研究者

相似试验